The Quiet Crisis in Companion Animal Health
What Every Pet Brand Needs to Know about Joint Health in Animals Walk into any veterinary clinic on a Tuesday afternoon, and you'll see it. The older poodle struggling to climb
Read More
What Every Pet Brand Needs to Know about Joint Health in Animals Walk into any veterinary clinic on a Tuesday afternoon, and you'll see it. The older poodle struggling to climb
Read MoreMillions of people are using GLP-1 drugs. Millions more are coming off them. Tens of millions are watching from the sidelines: wanting to lose weight, but unable to afford hefty
Read MoreOral health is one of the fastest-growing segments in the pet supplement space, and pet owners are spending more on their companion animals than ever before. Smart brands are stepping
Read MoreGLP-1 agonists have rewritten the rules of weight management almost overnight—and in the process created one of the biggest nutrition challenges (and opportunities) formulators have seen in decades. For brands paying
Read MoreUnderstanding Metabolic Health Consumers today want more energy, sharper focus and lasting wellness—and the conversation keeps circling back to one thing—metabolic health. Why is it front and center? Surging GLP-1 use Increasing
Read MoreGLP-1 therapies have changed the metabolic health conversation, fast. Millions now rely on GLP-1 medications to support weight management and glycemic control. The benefits are real, but so are the nutritional
Read MoreThe Missing Ingredient in Your Sports Nutrition Portfolio? Systemic Enzymes Performance sells. But recovery? Recovery wins. The sports nutrition space has spent decades obsessing over pre-workout energy, intra-workout endurance and post-workout protein.
Read MoreGLP-1 drugs like Ozempic and Wegovy are reshaping weight management. The results are undeniable—but the side effects are too. That’s why companion solutions aren’t optional anymore. They’re essential. Why Gut Health
Read MoreConsumers are flooded with weight loss options—from exercise apps to intermittent fasting to ketogenic diets. But nothing is making waves like GLP-1s. GLP-1 agonists, such as Ozempic and Wegovy, are transforming
Read MoreThe 65+ population is growing fast, and so are their health needs. The question is no longer if the market is ready; the question is, are you? 1 in 5
Read More